VIA.F VIATRIS INC. O.N.

Healthcare Drug Manufacturers - Specialty & Generic Frankfurt Exchange
18.85 EUR
Close of Nov 12, 2026
8.49 19.14
Market cap
EUR 21.6B
P/E
-
P/B
1.72x
ROE
-2.6%
Dividend yield
2.34%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is VIA.F undervalued?

Graham number

The Graham number of VIATRIS INC. O.N. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VIATRIS INC. O.N. fundamental analysis

No fundamental analysis for VIATRIS INC. O.N. yet.

VIATRIS INC. O.N. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VIATRIS INC. O.N.

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering variou…

Full company profile